查找! 分享! 健康知识
注:参考资料
1. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA: Intravenous Tissue-type plas- minogen activator for treatment of acute stroke. JAMA 283: 1145~1150,2000
2. Carter BS, Ogilvy CS, Candia GJ, Rosas HD, Buonanno. F: One-year outcome after decom- pressive surgery for massive nondominant hemis- pheric infarction. Neurosurgery 40: 1168-1176, 1997.
3. Delashaw JB, Broaddus WC, Kassel NF, Haley EC, Pendleton GA, Vollmer DG, Maggio WW ,Grady MS: Treatment of right of right hemispheric cerebral infarction by hemicraniectomy. Stroke 21:874-881, 1990
4. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M: PROACT:A Phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke- PROACT Investigatiors: Prolyse in Acute Cerebral Thromboembolism. Stroke 29:4-11, 1998
5. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Riversa F: Intra-arterial prourokinase for acute ischemic stroke: The PROACT II Study-A randomized controlled trial : Prolyse in Acute Cerebral Thromboembolism. JAMA 282: 2003-2011, 1999
6. Guetra WKW, Gaab MR, Dietz H, et al : Surgical decom- pression for traumatic brain swelling : indications and results. J Neurosurg 90: 187- 196. 1999
7. Hacke W , Kaste M, Fieshi C, Toni D, Lesaffre E , von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne M, Hennerici M, Safety and efficacy of intravenous thrombolysis with a recom- binant tissue plasminogen activator in the treatment of acute hemispheric stroke: results of ECASS , THE European Cooperative Acute Study. JAMA. 1995: 274: 1017 -1025.
8. Hacke W, Schwab S, horn M, Spranger M, De Georgia M,von Kummer R. Malignant middle cerebral artery territory infarction : clinical course and prognostic signs. Arch Neurol. 53:309-315, 1996.
9. B Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL. Hinchey JA, Hammel JP, Qu A, Sila CA: Use of tissue-type plasminogen activator for acute ischemic Stroke. JAMA 283: 1151~1158, 2000.
10. Lansberg MG, tong DC, Norbash AM, Yenari MA, Moseley ME: Intra-aterial rtPA treatment of stroke assessed by diffusion-and perfusion weighted MRL Stroke 30: 678-680, 1999.
11. Lewandowski CA, Frankel M, Tomsick T, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Spilker J, Khoury J, Brott T: Combined intravenous and intra- arterial therapy of acute ischemic stroke: Emergency Management of Stroke(EMS) Bridging Trial. Stroke 30:2598-2605, 1999.
12. Polin RS, Shaffrey ME, Bogaev CA, et al : Decom- pressive bifrontal craniecomy in the treatment of severe refractory posttraumatic cere- bral edema. Neurosurgery 41:84-94,1997.
13. Qureshi AI, Luft AR, Sharma M, Guterman LR, Hopkins LN: Prevention and treatment of thromboembolic and ischemic complication asscioated with endovascular procedures : Part I - Pathophysiological and pharmacological features. Neurosurgery 46: 1344-1359, 2000.
14. Rieke K, Schwab S, Krieger D, von Kummer R, Aschoff A, Hacke W. Decompressive surgery in space occupying hemispheric infraction: results of an open, prospective study. Crit Care Med. 23: 1576-1587, 1995.
15. Ropper AH, Shafran B, Brain edmia after stroke: clinical sydrome and intracranial pressure. Arch Neurol. 41: 26 -29, 1984.
16. Schwab S, Steiner T, Aschoff A. Schwaz S, Steiner HH, Jansen O, Hacke W:Early hemicraniectomy in patient with complete middle cerebral artery infarction. Stroke 29: 1888-1893, 1998.
17. Suarez JI, Sunshine JL, Tarr, R, Zardat O, Selman WR, Kernich C, Landis DM: Predictors of clinical improvement, angio- graphic recana- lization, and intracranial hemorrhage after intra-arterial thrombolysis for cute ischemic stroke. Stroke 30: 2094-2100, 1999.
18. Suarez JI, Zaidat OO, Sunshine JI, Tarr R, Selman WR Landis D: Endovascular administration after intravenous infusion of throbolytic agent for the treatment of patients with acute ischemic strokes. Neurosurgery 50: 251-260, 2002.
19. The National Insstitute of Neurological Disorders and Stroke t-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med. 333: 1581-1587, 1995.
20. Wagner S, Schnippering H, Aschoff. A, Koziol JA, Schwab S, Stteiner T: Suboptimum hemicranieectomy as a cause of additional cerebral lesions in patients with malignant infarction of the middle cerebral artery. J Neurosurg 94; 693~ 696, 2001
21. Wong WJ, Hu HH, Luk Yo, Cherng CM, lien LM, Chen JR, Chiu HC, Ann MY, Jong GP, Kuo TH, Chang KC, Tan Tr, Liou CW: Intravenous thrombolytic therapy an acute ischemic stroke in Taiwan. Taiwan Crit Care Med 3: 112~ 120, 2001.
22. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C: Local intraarterial fibrinolytic therapy in patients with stroke: Urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 35: 159-162, 1993.